Candriam S.C.A. Relay Therapeutics, Inc. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 1,092,705 shares of RLAY stock, worth $5.29 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,092,705

Previous 703,429 55.34%

Holding current value

$5.29 Million

Previous $4.59 Million 68.69%

% of portfolio

0.05%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.23 - $9.51 $2.43 Million - $3.7 Million	389,276 Added 55.34%	1,092,705 $7.74 Million
Q2 2024 Aug 05, 2024	BUY	$5.9 - $8.02 $1.15 Million - $1.56 Million	195,000 Added 38.35%	703,429 $4.59 Million
Q1 2024 May 03, 2024	SELL	$7.5 - $12.07 $1.59 Million - $2.57 Million	-212,641 Reduced 29.49%	508,429 $4.22 Million
Q4 2023 Feb 14, 2024	SELL	$6.01 - $11.48 $1.5 Million - $2.87 Million	-250,000 Reduced 25.74%	721,070 $7.94 Million
Q2 2023 Aug 08, 2023	SELL	$9.99 - $18.27 $2.68 Million - $4.89 Million	-267,802 Reduced 21.62%	971,070 $12.2 Million
Q4 2022 Feb 13, 2023	BUY	$14.16 - $24.02 $1.13 Million - $1.91 Million	79,451 Added 6.85%	1,238,872 $18.5 Million
Q3 2022 Nov 10, 2022	BUY	$18.07 - $31.37 $10.9 Million - $18.9 Million	601,604 Added 107.85%	1,159,421 $25.9 Million
Q2 2022 Aug 03, 2022	BUY	$13.31 - $34.88 $1.95 Million - $5.11 Million	146,401 Added 35.58%	557,817 $9.34 Million
Q1 2022 May 13, 2022	SELL	$20.26 - $32.36 $2.4 Million - $3.83 Million	-118,469 Reduced 22.36%	411,416 $12.3 Million
Q4 2021 Feb 10, 2022	SELL	$26.0 - $37.03 $859,378 - $1.22 Million	-33,053 Reduced 5.87%	529,885 $16.3 Million
Q2 2021 Jul 20, 2021	BUY	$27.5 - $38.19 $15.5 Million - $21.5 Million	562,927 Added 5117518.0%	562,938 $20.6 Million
Q1 2021 Apr 29, 2021	BUY	$32.52 - $61.53 $357 - $676	11 New	11 $0

Others Institutions Holding RLAY

# of Institutions

204

Shares Held

156M

Call Options Held

207K

Put Options Held

40K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $582M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account